A new report by data analysts highlights a trend many in cardiology have already noticed: the continued prominence of AI-powered solutions designed to diagnose and treat CVD. 

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 

Following medical discharge, a program consisting of at-home visits, telehealth appointments and clinic visits resulted in better outcomes and lower healthcare costs than typical post-discharge care.

An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events. 

The newly cleared device works like a traditional scale, but it captures more data than just the user's weight. 

Researchers from Cleveland Clinic reviewed data from more than 400 patients, presenting their findings in the American Journal of Cardiology.

Detecting in-stent restenosis via coronary CTA with hybrid iterative reconstruction has historically been an exercise in avoiding false positives.

Few hospitals are actually complying with price transparency rules nearly two years after they were implemented.